The Centre has ruled out door-to-door vaccination of people and said the inoculation will be done at identified COVID Vaccination Centres, both government and private, registered on COWIN for 'good, germane and rational reasons'.
Dr Kanchan Sanyal, health and wellness advisor at Columbia Pacific Communities, a healthcare group, shares some crucial tips to stay safe.
The tally of active cases now comprises 0.05 per cent of the total infections.
According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.
'Promises of free vaccination, it appears, are good only for winning elections, and dumping the people thereafter'
Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the Central Drugs Standard Control Organisation (CDSCO) will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.
According to the Indian Council of Medical Research, 19,01,48,024 samples have been tested up to January 21 with 8,00,242 samples being tested on Thursday.
While some states are carrying out vaccination twice a week some others are carrying out four or more than four times a week.
The central government had announced that the vaccination for those above 18 years will begin across the country from May 1 as part of the third phase of the inoculation drive.
Protesting farmer leaders in the vulnerable age group Monday said they are not afraid of coronavirus and won't take vaccine jabs, even as the second phase of vaccination drive got underway to inoculate senior citizens and those above 45 with underlying medical conditions.
While it is not clear whether the volunteer had received the vaccine or a placebo shot during the trial, Anvisa has refused to reveal any more information citing reasons of medical privacy, CNN reported.
The company said it had conducted two separate trials for its intranasal Covid vaccine, one as a primary dose schedule and another as a booster dose, for subjects who have been double vaccinated with the two commonly administered Covid vaccines in India.
The daily positivity rate has been recorded at 2.46 per cent. It has been less than three per cent for the last 19 days, according to the data.
The government is helping vaccine manufacturers get more production units, financing and supply of raw materials, the Prime Minister's Officer said on Friday after Prime Minister Narendra Modi reviewed the progress of the country's COVID-19 vaccination drive.
India, which has shipped 'Made In India' COVID-19 vaccines to around 25 nations, on Wednesday urged the international community to stop 'vaccine nationalism' and actively encourage 'internationalism', underlining that hoarding superfluous doses will defeat global efforts to attain collective health security and combat the pandemic.
The Indian Olympic Association (IOA) on Thursday said all the Tokyo Games-bound athletes and officials have got their first COVID-19 vaccine and they will get their second doses before their departure from the country for the multi-sporting spectacle.
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
Over 3 lakh children between 12 and 14 years have received their first shot of Covid vaccine taking the total doses administered in the country to over 180.80 crore, according to Union health ministry data.
Pfizer Inc and BioNTech SE have said that their vaccine candidate has been found to be more than 90 per cent effective in preventing COVID-19.
"It has been decided that for approval of COVID-19 vaccines in India for restricted use in emergency situation which are already approved for restricted use by US Food Drug Administration, European Medicines Agency, UK Medicines and Healthcare products Regulatory Agency, Pharmaceuticals and Medical Devices Agency Japan or which are listed in WHO Emergency Use Listing and which are well established vaccines from the stand point that millions of individuals have already been vaccinated with the said vaccines, the requirement of conducting post approval bridging clinical trials and of testing every batch of vaccine by CDL, Kasauli can be exempted, if the vaccine batch/lot has been certified and released by National Control Laboratory of country of origin," it said.
Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture 10-12 crore doses annually.
The COVID-19 case fatality rate stands at 1.44 per cent.
The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.
The daily rise in new coronavirus infections have remained below 30,000 for 11 straight days.
The Brihanmumbai Municipal Corporation told the Bombay High Court on Monday that it does not apprehend a third wave of the COVID-19 pandemic in the city as the vaccination drive is going on smoothly, with over 42 lakh people fully vaccinated and over 82 lakh people having received the first dose.
The Centre has said that on-site registration for COVID-19 inoculation for healthcare and frontline workers aged 18 to 44 years will now only be available at government COVID vaccination centres.
With the fresh cases, India's COVID-19 tally climbed to 3,42,96,237.
India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.
A 48-year-old Anganwadi worker in Manipur has died a week after receiving her first dose of COVID-19 vaccine, officials said on Saturday.
In its daily situation report, the WHO said there is no evidence that the BCG vaccine protects people against COVID-19.
In India, Opposition parties along with healthcare professionals have urged the government, including Prime Minister Narendra Modi and top leaders, to take either of the Covishield or Covaxin doses, which could help in drastically reducing trust and fear issues amongst citizens., reports Sohini Das.
India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the United States company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center.
The Union Health Ministry on Friday asked all states and union territories to initiate vaccination of frontline workers against COVID-19 from the first week of February.
The nature of the adverse reaction and when the development took place were not initially clear, although the participant is expected to recover, said an individual familiar with the matter.
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.
The number of people who have recuperated from the disease surged to 2,48,93,410 and the case fatality rate has increased to 1.16 per cent
The death toll climbed to 5,24,181 with 24 fatalities, the data updated at 8 am stated.
The club said in a statement that they will observe a period of self-isolation in accordance with league and UK Government protocols on quarantine.
World leaders thanked India for its help and support in combating the coronavirus pandemic through "early and meaningful" shipments of COVID-19 vaccine doses, as they addressed the high-level UN General Assembly session this year.
The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances